TABLE 3.
Univariate and Multivariate Analyses of Factors Associated With Overall Survival, Disease-Free Survival, and Cancer-Specific Survival
| Overall Survival | Disease-Free Survival | Cancer-Specific Survival | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Uni. | Multi. | Uni. | Multi. | Uni. | Multi. | ||||
| Variable | P | HR (95% CI) | P | P | HR (95% CI) | P | P | HR (95% CI) | P |
| Age (yr) (<65 and ≥65) | 0.400 | 0.101 | 0.091 | ||||||
| Male | 0.333 | 0.544 | 0.310 | ||||||
| DM | 0.838 | 0.082 | 0.461 | ||||||
| Mal-N | 0.008 | 2.29 (1.60–3.29) | 0.001 | 0.028 | 1.13 (1.07–1.67) | 0.017 | 0.008 | 1.98 (1.06–1.59) | 0.016 |
| Preop. albumin (<3.5 and ≥3.5 g/dL) | 0.028 | 0.55 (0.34–0.89) | 0.016 | 0.082 | 0.778 | ||||
| Jaundice | 0.975 | 0.382 | 0.658 | ||||||
| Neoadj. CTx | 0.639 | 0.059 | 0.604 | ||||||
| EBL (<500 and ≥500) | 0.025 | 1.83 (1.27–2.68) | 0.001 | 0.018 | 0.86 (0.5–91.23) | 0.861 | 0.032 | 0.98 (0.65–1.51) | 0.948 |
| Cx | 0.332 | 0.715 | 0.770 | ||||||
| Adj. CTx | 0.145 | 0.852 | 0.398 | ||||||
| Tumor size (<3 and ≥3 cm) | 0.001 | 0.58 (0.11–0.87) | 0.011 | 0.196 | 0.001 | 0.51 (0.16–0.57) | 0.001 | ||
| Stage I versus IIA versus IIB versus III | 0.016 | 0.34 (0.11–1.05) | 0.061 | 0.002 | 0.69 (0.55–0.87) | 0.001 | 0.001 | 0.33 (0.20–0.52) | 0.001 |
Adj. indicates adjuvant; CI, confidence interval; CTx., chemotherapy; Cx., complication; DM, diabetes mellitus; HR, harzard ratio; Mal-N, malnutrition; Multi., multivariate analysis; Neoadj., neoadjuvant; Preop., preoperative; Uni., univariate analysis.